Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Finished Goods (2018 - 2025)

Immucell (ICCC) has disclosed Finished Goods for 8 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Finished Goods rose 8768.86% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Sep 2025, up 8768.86%, and an annual FY2024 reading of $9530.0, down 97.63% over the prior year.
  • Finished Goods was $2.0 million for Q3 2025 at Immucell, up from $1.2 million in the prior quarter.
  • Across five years, Finished Goods topped out at $2.0 million in Q3 2025 and bottomed at $9530.0 in Q4 2024.
  • Average Finished Goods over 5 years is $460858.2, with a median of $385811.0 recorded in 2023.
  • The sharpest move saw Finished Goods plummeted 97.63% in 2024, then soared 8768.86% in 2025.
  • Year by year, Finished Goods stood at $29381.0 in 2021, then surged by 410.04% to $149855.0 in 2022, then soared by 168.67% to $402619.0 in 2023, then tumbled by 97.63% to $9530.0 in 2024, then surged by 20645.5% to $2.0 million in 2025.
  • Business Quant data shows Finished Goods for ICCC at $2.0 million in Q3 2025, $1.2 million in Q2 2025, and $40747.0 in Q1 2025.